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Abstract
Background and Objectives: Persons living with dementia have complex care needs including memory loss that should be 
taken into account by providers and family caregivers involved with their care. The prevalence of comorbid conditions in 
people with dementia is high and, thus, how primary care, community providers and family caregivers provide best practice 
care, person-centered care is important.
Research Design and Methods: Care providers should understand the ongoing medical management needs of persons 
living with dementia in order to maximize their quality of life, proactively plan for their anticipated needs, and be as well 
prepared as possible for health crises that may occur.
Results: This article provides eight practice recommendations intended to promote understanding and support of the role 
of nonphysician care providers in educating family caregivers about ongoing medical management to improve the wellbeing 
of persons living with dementia.
Discussion and Implications: Key among these are recommendations to use nonpharmacological interventions to manage 
behavioral and psychological symptoms of dementia as the first line of treatment and recommendations on how to best 
support the use and discontinuation of pharmacological interventions as necessary.
Keywords:  Caregiving-formal, Dementia, Evidence-based practice, Person-centered care
In this article, we address the ongoing medical care that 
most people living with dementia need over the course of 
the disease. Persons living with dementia have complex 
care needs including memory loss, for example, that may 
impede their ability to take medicines on a regular basis 
or communication difficulties that make it more difficult 
for them to report symptoms that they may be experienc-
ing (Bunn et al., 2014). Persons living with dementia can 
have many of the same comorbid conditions that persons 
without dementia have, but frequently have more encoun-
ters with acute care providers, including doctors and nurses 
at hospitals and emergency departments. A recent system-
atic literature review by Bunn and colleagues (2014) sug-
gests that significant numbers of people with dementia 
have a comorbid health condition, such as diabetes, visual 
impairment, or stroke. Because this was a large review of 
over 65 studies, prevalence numbers varied, however, as 
Bunn and colleagues (2014) report the prevalence of type 
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2 diabetes ranged from 6% to 39% in people with demen-
tia; similarly 3% of hospitalized older adults in the United 
Kingdom to 34% of community dwelling older adults in 
a U.S. sample had a history of stroke and dementia. Two 
studies reported the prevalence of dementia in people with 
visual impairment recruited via eye clinics. In one 19% of 
people with macular disease had dementia and in the other 
20% of people with glaucoma had memory impairment 
and 22% impaired executive functioning.
There may be a variety of factors that contribute to this 
finding. For example, people with dementia may be less 
likely to attend regular appointments or to notice or report 
relevant symptoms and they may be more reliant on caregiv-
ers to manage and facilitate appointments. It is also possible 
that clinicians may be more reluctant to investigate and treat 
individuals with dementia either because of the difficulties 
involved in securing cooperation or because treatments are 
considered inappropriate for older patients with multiple 
comorbidities. In addition, if dementia is symptomatic, then 
the dementia can become clinically dominant and detract 
from the management of other conditions like diabetes mel-
litus (Bunn et al., 2014). It is useful for nonphysician care 
providers to understand how care ideally should be provided 
to persons with dementia in order to maximize their quality 
of life, proactively plan for their anticipated needs, and be 
as well prepared as possible for health crises that may occur.
As reviewed earlier in this special issue, the number of 
persons affected by Alzheimer’s disease and other demen-
tias is projected to increase over the coming decades. With 
these increases, we can expect to see a greater demand for 
services for persons living with dementia across all health 
care settings, though it might be expected that this demand 
will be greatest in those venues that most commonly pro-
vide care to persons living with dementia today. Some of 
these settings, such as memory care centers and long-term 
care centers including nursing homes, have long-standing 
experience in providing care to large numbers of persons 
living with dementia; whereas in other settings, including 
primary care offices, medical specialists’ offices, hospitals, 
and emergency departments, more preparation will be 
needed to address the unique care needs of persons living 
with dementia as their numbers increase.
For clarity, this article uses the terms, physician, medi-
cal care provider, primary care provider, and acute care 
provider, to refer to physicians and medical care provid-
ers including nurse practitioners and physician assistants 
who work in primary care offices, medical specialist offices, 
hospitals, and emergency departments. It uses the terms, 
family, family members, and caregivers to refer to relatives, 
friends, and neighbors who provide care for a person liv-
ing with dementia. Lastly, it uses the terms, nonphysician 
care provider and community or residential care provider, 
to refer to individuals who work in area agencies on aging, 
aging and disability resource centers, information and 
referral agencies, senior centers, senior housing, personal 
care homes, assisted living facilities, nursing homes, home 
health agencies, homemaker and personal care agencies, 
care management agencies, adult day centers, pharma-
cies, and public health and community nursing agencies. 
Examples might include pharmacists; social workers, physi-
cal, occupational, and speech therapists. Nonphysician care 
providers also include self-employed geriatric care consult-
ants, family counsellors, and home care aides.
Understanding Common Comorbidities
It is important for nonphysician care providers who work 
in community and residential care settings to remember 
that persons living with dementia have medical care needs 
in addition to care needs related to the dementia. Typically, 
medical care for the person living with dementia is pro-
vided by a family medicine physician or internist, who 
often works with a neurologist or psychiatrist depending 
on the person’s needs. Persons living with dementia may see 
several doctors, therefore, having a consistent relationship 
with a primary care provider can help coordinate care and 
potentially prevent unnecessary hospitalizations. Family 
caregivers should expect that physicians and medical care 
providers across all health care settings should provide care 
to persons living with dementia in a manner that respects 
their personhood, takes into account the variable ability of 
individuals living with dementia to participate in or direct 
their health care, and reflects the high likelihood concerned 
family members should be involved and included in any 
medical decision making. Like other older adults, persons 
living with dementia commonly suffer from high blood 
pressure, heart disease, diabetes, as well as other conditions 
that become more common with age. Care for these com-
mon conditions should not be provided in isolation from 
the person’s dementia but rather take the person’s dementia 
into account (Bunn et al., 2014; Schubert et al., 2006).
Medical issues can worsen cognition, and many people 
living with dementia have other conditions that can and do 
impact cognition. Unfortunately, it can be difficult to rec-
ognize when the person living with dementia is ill. Persons 
living with dementia are known to be less likely to report 
symptoms or by the time they are asked about them, the 
symptoms have passed, and they can’t give an accurate 
report. Often, the only symptom one can see is the worsen-
ing of confusion or behaviors, which makes it very difficult 
to know if this is due to the progression of the underly-
ing dementia or if there is a new problem to be addressed. 
When there is a significant and sudden change in cognition 
and behavior, it is important that the person with dementia, 
their caregiver and involved nonphysician care providers 
report this to the person’s primary care provider quickly.
In order to assure that persons living with dementia and 
their caregivers receive medical care and other services that 
are consistent with their goals of care, they need to be first 
offered an explanation of the condition, its prognosis, and 
potential treatment options, including pharmacologic and 
nonpharmacologic approaches. Evidence to date suggests 
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that only a minority of persons living with dementia are 
recognized as having the condition by their primary care 
providers and that their caregivers experience increased 
levels of stress, depression, and mortality (Boustani, Sachs, 
& Callahan, 2007; Fowler, 2012; McKhann et  al., 2011). 
There are evidence-based programs that support the process 
of identifying and diagnosing persons with dementia, pro-
vide on-going support to them and their caregivers, and help 
address their on-going and evolving biopsychosocial needs 
(Callahan et al., 2014; LaMantia et al., 2015; Tan, Jennings, 
& Ruben, 2014). Speaking with persons living with demen-
tia and their caregivers about the diagnosis of dementia 
should not be done in a hurried manner, but rather should be 
approached with sensitivity and in a manner that recognizes 
the particular needs of each individual (Wilkinson & Milne, 
2003). Further, speaking with persons living with dementia 
and their caregivers about the diagnosis and its prognosis 
does not need to be done in an overly negative manner that 
removes hope. Instead, an approach that acknowledges and 
incorporates the many advances that have been made in 
addressing the medical and social needs of the person living 
with dementia and their caregivers is recommended.
Persons living with dementia and their family mem-
bers often fear that after the diagnosis, their physician will 
abandon them because there are currently no disease modi-
fying treatments available (Boustani et  al., 2011; Fowler 
et al., 2012). Physicians and other medical care providers 
can offer important education and psychosocial support 
to both the person with dementia and the family caregiver 
(Austrom & Lu, 2009; Callahan et  al., 2011; McKhann 
et  al., 2011). Medical care providers also have a unique 
opportunity to educate the person living with dementia 
and their family members about what to expect over the 
course of disease. Indeed, the needs of persons with demen-
tia can be expected to change over time. Early on, medical 
providers, nonphysician care providers, and caregivers may 
need to provide little additional support than that which is 
given to persons without dementia, however with time the 
amount of support should be titrated gradually in a per-
sonalized manner that responds to the individual’s unique 
pattern of increasing need and respects his or her autonomy 
(Callahan, 2017). Medical providers can, additionally, pro-
vide referrals to available support services and can monitor 
judgment and safety issues so that the person living with 
dementia can remain independent and community-dwell-
ing for as long as possible (Boustani et al., 2011; Callahan 
et  al., 2012; Farran et  al., 2007; Schulz et  al., 2003). 
Nonphysician care providers can play an instrumental role 
in supporting person living with dementia and their care 
partners after they have been diagnosed by their physician.
Addressing Behavioral and Psychological 
Symptoms of Dementia
One of the more common complications that can arise in 
the care of persons living with dementia is the development 
of behavioral disturbances. Such symptoms are thought to 
occur in between 75% and 98% of community dwelling 
individuals and can become more common as the demen-
tia progresses. Symptoms can include agitation, wandering, 
resistance to care, combativeness, nighttime arousals that 
interfere with sleep and caregivers’ sleep, and psychotic 
symptoms (Ballard & Waite, 2006; Fung et al., 2012; Sink, 
Covinsky, Newcomer, & Yaffe, 2004; Teri et al., 2000). It 
is important that families and nonphysician care providers 
bring these symptoms to the physician’s attention so that 
the symptoms may be evaluated thoroughly and a plan for 
their management developed.
In evaluating the person’s behavioral disturbance, it is 
important that the context in which the behavior occurs is 
considered. This information is most often obtained from 
family members or a nonphysician care provider. These 
individuals may be most able to describe whether this is a 
continuation of an old behavior that should come to med-
ical attention for some other unrelated reason or describe 
accurately if this is a new or worsening symptom. A use-
ful framework for physicians in making an evaluation of a 
new symptom is that initially developed by Sharon Inouye 
(Inouye, 1999; Inouye & Charpentier, 1996) to describe 
delirium. This framework consists of predisposing factors 
inherent to the individual which set the stage upon which 
precipitating factors then cause the concerning behavior 
to occur. In this model, examples of predisposing factors 
could include the stage of the person’s dementia, the pres-
ence of chronic comorbid illnesses like congestive heart fail-
ure or chronic obstructive pulmonary disease, and sensory 
impairments like decreased hearing ability or decreased 
vision caused by cataracts, glaucoma, or macular degener-
ation for example. Precipitating factors might include the 
use of sedating or stimulating medications, the presence of 
untreated pain, exposure to frightening or disturbing stim-
uli, the inability of the individual to get adequate rest, the 
removal of the person from his or her usual environment or 
normal routine, and the development of delirium (Inouye, 
1999).
In a recent study by Kerns and colleagues (2017), family 
caregivers and nurses of persons with dementia living in 
the community and in residential care, were interviewed for 
their perceptions on the use of both nonpharmacological 
interventions and medications for behavioral disturbances 
(Kerns, Winter, Winter, Kerns, & Etz, 2017). Caregivers 
were able to identify three major issues regarding medi-
cations for persons with dementia including (a) barriers 
exist for nonpharmacologic therapies and these should be 
addressed; (b) medications have few barriers, and seem 
generally effective and safe; and (c) when nonpharmaco-
logic measures fail, medications, including antipsychotics, 
may be necessary and appropriate to relieve the person 
with dementia’s distress. This study highlights the import-
ant voice that caregivers, both family members and nurses, 
can bring to person-centered care (Kerns, Winter, Winter, 
Kerns, & Etz, 2017).
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As noted above, medications can be the cause of newly 
developing behavioral disturbances among persons living 
with dementia. The astute family member and nonphysi-
cian care provider should be suspicious when a new or con-
cerning behavior occurs soon after a new medication has 
been started. Similarly, concern should be raised if the per-
son living with dementia develops new behavioral symp-
toms and may not be receiving their medications as they 
have been prescribed, either because the medicine is being 
taken at the wrong dose or it is being taken too frequently, 
not frequently enough, or at the wrong times. As adults age, 
their bodies process medications differently than they did 
when they were younger and as a result, there are medica-
tions that some persons living with dementia have taken 
for years but no longer tolerate as their body ages and 
as their brains become more vulnerable with the worsen-
ing of their condition. Of particular concern is the use of 
anticholingeric medications in older adults and the nega-
tive impact on cognitive function. A review of the literature 
by Boustani and colleagues (2008) found that prescribing 
anticholinergics to older adults can lead to acute cogni-
tive impairment and might even lead to chronic cognitive 
deficitis (Boustani, Campbell, Munger, Maidment, & Fox, 
2008). Given changes in responses to medication over time, 
it is very important for family members and/or nonphysi-
cian care providers to attend routine doctors’ appointments 
with the person living with dementia; to make sure that 
they bring all medications, supplements, and herbs with 
them to the appointments whether these are prescribed 
or taken over-the-counter; and that they discuss with the 
person’s physician whether all of the medications continue 
to be needed. The physician should welcome this type of 
information and these types of conversations as they help 
the family and nonphysician care providers deliver care 
that is personalized and appropriate to the needs of the per-
son living with dementia. Physicians and other medical care 
providers that are not welcoming or supportive of person-
centered care for the person living with dementia and par-
ticipatory care with the family caregiver, may not be the 
most appropriate provider for the person with dementia 
and caregiver dyad.
Family caregivers and nonphysician care providers 
should expect that the medical provider will start with the 
lowest effective dose of a medication then reevaluate the 
person living with dementia for anticipated side effects and 
effectiveness of the medication before deciding whether 
to continue the medicine, increase its dose, or discontinue 
it. A  useful tool to consult when evaluating the need to 
start, continue, or discontinue a medication for an older 
adult and particularly those with dementia is the Beers 
List (AGS, 2015). This list, originally developed by phy-
sician Mark Beers in 1991 and updated most recently in 
2012, includes 34 medicines and classes of medicines that 
are “potentially inappropriate” in older adults. Examples 
of these include benzodiazepines, like lorazepam which 
may be used to address anxiety but can increase the risk 
of falls or confusion in an older adult, or anticholinergic 
medications, like diphenhydramine which may be used to 
treat allergic symptoms in an urgent or emergent situation 
but can cause confusion or fatigue in a vulnerable senior 
and should not be used for treating either sleep issues or 
anxiety. Asking medical providers about the necessity of all 
prescribed medicines and understanding the indication for 
their use can be an important way for family caregivers and 
nonphysician care providers to be effective advocates for 
persons living with dementia.
While medicines are clearly an important precipitant of 
behavioral disturbances among older adults, there are other 
important causes to consider. Pain is obviously still expe-
rienced by persons living with dementia though in more 
advanced stages of the condition the person’s reporting of 
pain may be impaired, take a different form, or be unrec-
ognized by others. In this situation, the report of a family 
caregiver or nonphysician care provider about increased 
irritability or grimacing during certain activities or at cer-
tain times of the day can be an important clue to pain’s role 
in the person’s behavior. To overcome the difficulty of the 
person living with dementia communicating their pain, it 
has been recommended that observational scales that help 
gauge the level of person’s pain be used. One such example, 
the PAINAD scale asks providers to observe and rate 
person’s outward behaviors across six domains that may 
correlate with the presence of pain: Breathing, negative 
vocalizations, facial expression, body language, and consol-
ability (https://www.healthcare.uiowa.edu/igec/tools/pain/
PAINAD.pdf). While any observational pain scale may rely 
to some extent on the skill of the observer and so neces-
sarily require some training on the part of the examiner, 
this approach nonetheless remains a valid attempt to over-
come the communication difficulties that many persons 
living with dementia experience as the condition advances 
(Rosenberg & Lyketsos, 2011). Research by Husebo and 
colleagues (2011) that measured and treated pain in a large 
sample of nursing home residents with late stage demen-
tia, showed that significant results in reducing pain and 
agitation were found with a relatively simple intervention 
and protocol that has been long approved by the American 
Geriatrics Society (1998). Developing an effective approach 
to the management of pain among persons living with 
dementia does not need to be complicated or to rely on the 
use of powerful pain control medications such as opioids; 
pain can potentially be controlled with milder medications 
that do not come with significant side effects at usual doses. 
Similarly, there is evidence that the use of acetaminophen, 
the main ingredient in a common over-the-counter pain 
medicine, can decrease agitation among persons living with 
dementia (Corbett et al., 2012).
Other common causes of behavioral disturbances 
among persons living with dementia can include exposure 
to frightening stimuli, sleep disruption, and the develop-
ment of delirium. Frightening or misunderstood stimuli can 
lead to behavioral disturbances that occur with bathing 
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or with cleaning after toileting. Others, whether brought 
on by persons that remind the older adult of an unpleas-
ant former acquaintance or that cause confusion, can take 
more detective work to identify. In either event, identifying 
the cause and thus the meaning of the concerning behav-
ior can be the first step in developing a plan to manage it 
(Rasin & Barrick, 2004).
Sleep disruptions are common and can be exacerbated 
by disruptions in person’s normal internal 24-hr clock, 
the circadian rhythm (Deschenes & McCurry, 2009; 
Dauvilliers, 2007). Cross-sectional studies have suggested 
that approximately 25%–35% of persons with Alzheimer’s 
disease have problems sleeping, and most likely due to the 
progressive deterioration and loss of neurons in the supra-
chiasmatic nucleus (Dauvilliers, 2007). Unfortunately, 
medications commonly used to treat negative behavioral 
symptoms of dementia and to slow disease progressions, 
often result in negative side effects that affect sleep and 
wakefulness (Dauvilliers, 2007; Wu & Swaab, 2007). 
Setting a consistent schedule, promoting a regular night-
time routine, finding a comfortable sleeping space with-
out excess noise, temperature, or light can all be initial 
steps that families and nonphysician care providers take 
to address this issue (Deschenes & McCurry, 2009; Wu & 
Swaab, 2007). Finally, delirium is a condition in which per-
sons, particularly those with dementia or other conditions 
which make their brains more vulnerable, typically display 
new and fluctuating symptoms of inattention and either 
disorganized thinking or altered levels of consciousness. If 
this condition is suspected, it is recommended that a family 
member or nonphysician care provider bring the condition 
to the medical provider’s attention, as further medical test-
ing and observation may be warranted.
Nonpharmacologic Interventions
Behavioral and psychological symptoms of dementia 
(BPSD) may become necessary. BPSD is a term used to 
describe a heterogeneous range of psychological reactions, 
psychiatric symptoms, and behaviors occurring in people 
with dementia of any etiology (Finkel & Burns, 2000). 
Managing BPSD is critical because the incidence of these 
have been shown to result in premature institutionaliza-
tion, increased financial cost, increased caregiver burden, 
poor quality of life for the person with dementia and their 
family caregiver as well as increased nursing stress (de 
Vugt et  al., 2005; Draper et  al., 2011; Herrmann et  al., 
2006; International Psychogeriatrics Association, 2000). 
The majority of persons living with dementia (75%–98%) 
develop some behavioral or psychiatric symptoms at some 
point in their illness (Ballard & Waite, 2006; Fung et al., 
2012; Sink, Covinsky, Newcomer, & Yaffe, 2004; Teri 
et al., 2000).
When providing care for a person living with demen-
tia, nonpharmacological interventions are preferred and 
should be tried first. Research on the effectiveness of 
nonpharmacological interventions has increased over the 
past few years and the interventions discussed below have 
shown positive impact on both the person living with 
dementia and the family caregiver. Indeed, a recent system-
atic review of systematic reviews in this area, found that 
while methodologies and sample sizes vary, music therapy 
and behavioral management techniques proved most ben-
eficial overall (Abraha et  al., 2017). In addition, Gitlin, 
Kales, & Lyketsos (2012) stress that nonpharmacologic 
interventions need to be included as first-line treatment for 
behavioral disturbances, or in conjunction with pharmaco-
logic treatments if necessary.
Activity and recreation have been shown to be beneficial 
to the person living with dementia. Encouraging participa-
tion in daily chores and maintaining hobbies and shared 
past activities have been shown to improve mood, reduce 
agitation, and improve quality of life for persons living with 
dementia. Twenty to sixty minutes of activity daily with skill 
level and interest well matched to that of the person living 
with dementia have been shown to have the most benefit (de 
Oliveira et al., 2015; Kolanowski, Litaker, & Buettner, 2005).
Educating family caregivers has been shown to be as 
effective at reducing agitation as medications (de Oliveira 
et al., 2015; Teri et al., 2000). Among the important things 
for family caregivers to learn is that a person living with 
dementia does not behave in these ways intentionally. 
Rather, the behaviors are manifestations of a brain disorder, 
and caregivers should not take personally anything the per-
son living with dementia says or does (Guerriero Austrom, 
Lu, & Hendrie, 2013). Knowing this can help avoid con-
flicts, anger, and subsequent feelings of guilt. Persons living 
with dementia cannot be held responsible for their behav-
iors, but all behavior has a purpose. It is up to the family 
caregiver to look for that underlying purpose. For example, 
a person living with dementia may be agitated and wander 
around the house because he has forgotten where the bath-
room is and he needs to use it. Or a person with dementia 
may constantly disrobe because she is too hot. The family 
caregiver should not blame the person living with dementia 
for these behaviors but should remain calm, try to figure 
out what is causing the behavior, and redirect the person 
living with dementia while protecting his or her dignity 
(Guerriero Austrom et al., 2013; Whitlatch, Judge, Zarit, 
& Femia, 2006). Nonphysician care providers can help 
to remind family caregivers that the person with demen-
tia is no longer acting with volition. Several psychosocial 
educational programs have been shown to be effective 
in increasing caregiver knowledge and understanding of 
person’s with dementia’s behaviors and challenges (Burns 
et al., 2003; Falcão, Bras, Garcia, Santo, & Nunez, 2015; 
Gitlin et al., 2012) leading to improved outcomes for both 
caregivers and patients. Care providers are encouraged to 
direct family caregivers to available resources (http://www.
alz.org/care; https://www.nia.nih.gov/alzheimers; https://
cicoa.org/services/careaware; http://www.actonalz.org/
dementia-friendly-toolkit).
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A person living with dementia will need care for many 
years. Successful caregiving is based on understanding the 
caregiver’s emotional response to the disease, to the per-
son living with dementia, and to the behaviors, which all 
change over time. Families must endure an ongoing grief 
process as they strive to cope with the demands of caregiv-
ing while watching the psychological death of their loved 
one and the death of that individual’s personality—that 
quality or assemblage of qualities that makes a person 
who he or she is. Many caregiving families fail to realize 
that grief is an appropriate response when caring for a per-
son with dementia (Austrom & Lu, 2009; Ott, Sanders, & 
Kelber, 2007; Schulz et al., 2012). Nonphysician care pro-
viders play an important role in supporting families as they 
grieve.
Exercise programs also have been shown to be beneficial 
in reducing agitation. In one study, persons with dementia 
who participated in a 3-week group exercise program for 
30  min per day (15  min of aerobic exercise and 15  min 
of resistance training) showed reduced agitation (Aman & 
Thomas, 2009; de Oliveira et al., 2015).
Pharmacologic Interventions
Despite best intentions, pharmacologic management of 
the behavioral and psychological symptoms of demen-
tia (BPSD) may become necessary. BPSD is a term used to 
describe a heterogeneous range of psychological reactions, 
psychiatric symptoms, and behaviors occurring in people 
with dementia of any etiology (Finkel & Burns, 2000). 
Managing BPSD is critical because the incidence of these 
have been shown to result in premature institutionaliza-
tion, increased financial cost, increased caregiver burden, 
poor quality of life for the person with dementia and their 
family caregiver as well as increased nursing stress (de Vugt 
et  al., 2005; Draper et al., 2011; Herrmann et al., 2006; 
International Psychogeriatrics Association, 2000). As many 
as 90% of persons living with dementia develop some 
behavioral or psychiatric symptoms at some point in their 
illness (Ballard & Waite, 2006; Fung et al., 2012).
It is important for nonphysician care providers to 
understand the basics of medications used to treat symp-
toms in person living with dementia. There is a role for 
the use of medications in the management of the progres-
sion of persons’ dementia as well the management of their 
comorbid illnesses. Any time that a medication is going 
to be used in an older adult, a careful assessment of the 
risks and benefits of the medication’s use is warranted with 
due consideration given to the goals of the person’s care 
and the stage of their dementia. Dementia-specific medica-
tions, such as acetylcholinesterase inhibitors and NMDA 
agonists, have received approval from the U.S. Food and 
Drug Administration (FDA) to treat cognitive symptoms 
associated with Alzheimer’s disease. These medications are 
prescribed with an aim of decreasing the rate of cognitive 
decline associated with the disease. No medications are 
currently approved for the treatment of the behavioral and 
psychological symptoms associated with Alzheimer’s dis-
ease. Indeed, any medications prescribed by a physician for 
treatment of these symptoms are “off label,” an approach 
in which a provider administers a medication for a reason 
other than the one for which the medicine was approved 
for use by the FDA.
Common medications that are used “off label” to treat 
the behavioral and psychological symptoms of dementia 
include antidepressant medicines, which are thought to tar-
get mood disturbances and agitation, benzodiazepines to 
target anxiety, and antipsychotic medications for the treat-
ment of hallucinations, agitation, and aggressive behavior. 
It should be noted that there has been particular concern 
raised by the use of antipsychotic medications among 
persons with dementia given research that is shown an 
increased risk of stroke and death associated with their use 
(Douglas and Smeeth, 2008; Gill et al., 2007; Schneeweiss, 
Setoguchi, Brookhart, Dormuth, & Wang, 2007). As a 
result, the FDA has issued a “black box warning” that 
warns providers about the increased risks that accompany 
use of these medicines. Careful evaluation, discussion with 
caregivers, and monitoring of persons with dementia would 
be warranted if use of antipsychotic medications were to be 
initiated. As with any medication started for an older adult, 
it is recommended that the need for continued use of these 
medications is reviewed periodically, that attempts be made 
to decrease their dose, and their use be discontinued when 
possible. As always, nonpharmacologic approaches to the 
management of dementia symptoms are preferred and it 
should be considered that the concurrent use of nonphar-
macologic approaches may decrease or eliminate the need 
for use of prescribed medications to address concerning 
behaviors. It is important for nonphysician care providers 
to understand the basics of medications used to treat symp-
toms in person living with dementia.
Crisis Planning and Management
Compared to older adults without dementia, persons with 
dementia visit the emergency department (ED) more fre-
quently, are hospitalized more often, return to the ED 
within 30 days of an initial ED visit at higher rates, and 
are at higher risk of death in the six months after an ED 
visit than persons without dementia (LaMantia, Stump, 
Messina, Miller, & Callahan, 2016). These data under-
score the vulnerable state of persons living with dementia 
who develop an acute illness. Preparing for a crisis before 
it occurs can be an important step that caregivers and com-
munity care providers take to ensure that persons living 
with dementia receive optimal care.
One of the most important steps that family caregivers 
can and should take to ensure that they are able to rep-
resent the person living with dementia is to participate in 
advance care planning discussions early in the state of the 
illness, while substantive conversations about wishes can 
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still be had. While many states recognize the right of family 
members to make medical decisions for loved ones when 
they can longer speak for themselves and have established 
clear hierarchies of precedence for delegating decision mak-
ing powers among relatives, not every state does so. As a 
result, it can be useful to establish a durable health care 
power of attorney designation early on in the course of 
the person’s illness. Forms to complete these designations 
are often available through state and local governments, 
local hospitals, and elder care attorneys. Forms frequently 
need to be notarized and may need to be filed with a local 
authority, depending on the jurisdiction, so it is recom-
mended to verify the appropriate procedures for setting 
this in place with an entity familiar with local laws and 
regulation. For individuals who learn that they are to be 
or seek to become someone’s health care power of attor-
ney, it is important that they speak with the person living 
with dementia about their health care values and wishes so 
that the person’s values and decisions can be represented 
if/when that time comes. While these conversations may 
be difficult to initiate, they are critical to have and many 
guidelines and materials are available on-line to help advise 
people on how to approach these (http://www.alz.org/care/
alzheimers-dementia-legal-documents.asp; http://www.nia.
nih.gov/alzheimers/legal-and-financial-issues-people-alz-
heimers-disease- resource-list). Nonphysician care provid-
ers can be a support to families as they navigate the process.
End-of-life Care
From these conversations, it may become clear that the per-
son living with dementia may wish to place limitations on 
the type of care that they receive if they were to become ill. 
In some areas, it may be possible to discuss end-of life care 
decisions with the physician or other medical care provider 
whether or not the person with dementia and their health 
care representative wish to put in place a do not resuscitate 
order often called a DNR, that would direct emergency ser-
vices personnel not to start resuscitation in the event that the 
person living with dementia were to experience cardiac arrest 
or needs assistance in breathing. Importantly, these orders still 
allow Medical care providers to offer treatments that would 
keep the person living with dementia comfortable, but with-
out interrupting the natural course of events. If a person were 
to have more specific ideas about the type of care they would 
like to receive, in many states they may elect to complete 
Physician Orders for Life-Sustaining Treatment (POLST) 
with their provider (Hickman, Nelson, Smith-Howell, & 
Hammes, 2014). These forms, when completed, help delin-
eate what types of care persons with serious illnesses seek to 
receive and forego towards the end of their lives.
Beyond these considerations, caregivers may wish to 
keep critical materials, including lists of medications, active 
medical conditions, names of treating providers, together 
in a folder that is easily accessible and can be brought to 
the emergency department or hospital if the person with 
dementia needs emergency care. Given that persons with 
dementia may have a hard time navigating an emergency 
department or staying in a hospital room on their own, it 
may be necessary for their caregivers to stay by their bed-
side to serve as their advocate, provide comfort to them, 
and explain to them what is happening. Such tasks can be 
exhausting and many caregivers find it helpful to establish 
a network of friends and family who potentially can rotate 
serving in these roles if extended medical care is needed. 
Negotiating networks of people who would be willing to 
step in if the need were to arise ahead of time can be use-
ful to maximize the likelihood that these tasks do not fall 
back on one person, who may become easily overwhelmed. 
Again, nonphysician care providers can be a huge support 
to families as they plan for end of life care and decisions.
Summary and Conclusions
On-going medical management for persons living with 
dementia is complex and can last for many years. Helping 
persons living with dementia and their family caregivers 
negotiate the medical maze over the course of the disease 
can reduce stress, improve care and the quality of life for 
both persons with dementia and their caregivers.
Recommendations for ongoing medical man-
agement to maximize health and well-being 
for persons living with dementia
Nonphysician care providers who work with persons 
living with dementia and their families in community or 
residential care settings should:
1. Take a holistic, person-centered approach to care and 
embrace a positive approach to the support for persons 
living with dementia and their caregivers that acknowl-
edges the importance of individuals’ ongoing medical 
care to their well-being and quality of life. Nonphysician 
care providers must adopt a holistic approach to provid-
ing care and ongoing support to the person living with 
dementia and their family caregivers. They should work 
to reduce existing barriers to coordination of medical 
and nonmedical care and support. Adopting a positive 
approach towards care can reduce real or perceived mes-
sages of hopelessness and helplessness and replace these 
with positive messages and an approach that encourages 
persons living with dementia and their caregivers to seek 
support and care over the course of the disease.
2. Seek to understand the role of medical providers in the 
care of persons living with dementia and the contribu-
tions that they make to care. Nonmedical care provid-
ers and family caregivers should work with medical 
providers towards developing a shared vision of care to 
support the person living with dementia.
3. Know about common comorbidities of aging and demen-
tia and encourage persons living with dementia and their 
families to talk with the person’s physician about how 
to manage comorbidities at home or in residential care 
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settings. Common comorbidities can negatively impact a 
person living with dementia, and conversely, a diagnosis 
of dementia can make the treatment and management 
of comorbid conditions quite challenging. Nonmedical 
care providers should encourage persons living with 
dementia and their families to report acute changes in 
health and function to the person’s physician, and to let 
the physician know about difficulties they encounter in 
managing acute and chronic comorbidities at home or in 
a residential care facility.
4. Encourage persons living with dementia and their fami-
lies to use nonpharmacologic interventions for common 
behavioral and psychological symptoms of dementia 
first. Increasing evidence suggests nonpharmacological 
interventions are effective at managing behavioral and 
psychological symptoms of dementia. Community care 
providers should encourage persons with dementia and 
their families to try these interventions first before con-
sidering pharmacological treatments.
5. Understand and support the use of pharmacological 
interventions when they are necessary for the person’s 
safety, well-being, and quality of life. Although nonphar-
macological interventions are preferred, there are times 
when pharmacological treatment is warranted for behav-
ioral and psychological symptoms. It is important for 
community care providers to understand that pharmaco-
logical treatment can have value for the person living with 
dementia in certain situations and to help them and their 
family caregiver to accept such treatment. Community 
care providers should also understand the general prin-
ciples for starting and more importantly, ending pharma-
cological treatments and encourage the person living with 
dementia and family caregivers to ask their medical pro-
viders for regular medication reviews and to consider the 
discontinuation of medications when appropriate.
6. Work with the person living with dementia, the fam-
ily, and the person’s physician to create and implement 
a person-centered plan for possible medical and social 
crises. It is helpful for persons living with dementia and 
their caregivers to have a plan in place should a medical 
or social crisis occur, such as an illness, hospitalization 
or the death of a caregiver. Having a plan in place will 
help the person’s physician and community care pro-
viders provide care and support that reflects the pref-
erences of the person living with dementia and reduce 
stress for family members and care providers who have 
to make decisions for the person during a crisis.
7. Encourage persons living with dementia and their fami-
lies to start end-of-life care discussions early. Persons 
living with dementia and their caregivers should under-
stand options available for care during the later stages 
of Alzheimer’s disease. Having discussions early with 
the person’s physician and other care providers and 
communicating the preferences of the person and fam-
ily across care settings can make the transitions during 
the progression of dementia more manageable.
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